The Enterprise Value as of December 2024 (TTM) for Magenta Therapeutics, Inc. (MGTA) is -114170976.00

According to Magenta Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -114170976.00. This represents a change of 59.40% compared to the average of -71627049.62 of the last 4 quarters.

Magenta Therapeutics, Inc. (MGTA) Historical Enterprise Value (quarterly & annually)

How has MGTA Enterprise Value performed in the past?

The mean historical Enterprise Value of Magenta Therapeutics, Inc. over the last ten years is 42.11M. The current -114170976.00 Enterprise Value has changed -27215.61% with respect to the historical average. Over the past ten years (40 quarters), MGTA's Enterprise Value was at its highest in in the December 2019 quarter at 527.21M. The Enterprise Value was at its lowest in in the September 2023 quarter at -153878736.96.

Magenta Therapeutics, Inc. (MGTA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Magenta Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Magenta Therapeutics, Inc. (MGTA) Average Enterprise Value

How has MGTA Enterprise Value performed in the past?

The current Enterprise Value of Magenta Therapeutics, Inc. (MGTA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Magenta Therapeutics, Inc. (MGTA) Enterprise Value vs. Peers

How is MGTA’s Enterprise Value compared to its peers?

Magenta Therapeutics, Inc.’s Enterprise Value is less than Assembly Biosciences, Inc. (68.46M), less than Instil Bio, Inc. (217.08M), less than Nuvation Bio Inc. (889.89M), less than Achilles Therapeutics plc (-35988955.00), less than NextCure, Inc. (4.32M), less than Spero Therapeutics, Inc. (-20420892.00), less than Neoleukin Therapeutics, Inc. (-6333315.00), less than CytomX Therapeutics, Inc. (54.15M),

Build a custom stock screener for Magenta Therapeutics, Inc. (MGTA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Magenta Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Magenta Therapeutics, Inc. (MGTA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Magenta Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.